Results for:(81 found)
Apr 9, 2012 10:51AM on Top StocksBy Melly Alazraki

The test can help clinicians and patients get more answers about their conditions.

Apr 2, 2012 11:02AM on Top StocksBy Melly Alazraki

The biotech has brighter prospects than its valuation suggests.

Apr 2, 2012 9:59AM on Top StocksBy

The generics drugmaker plans to tackle AstraZeneca's blockbuster antipsychotic drug Seroquel next.

Mar 2, 2012 11:19AM on Top StocksBy MSN Money Partner

Travelers is downgraded to 'equal weight,' and Boeing is initiated with a 'buy.'

Feb 7, 2012 1:12PM on Top StocksBy TheStockAdvisors

This screen for free cash flow to equity isolates stocks with both high yields and secure dividends.

Feb 2, 2012 7:39PM on Top StocksBy Benzinga

The company's Bydureon diabetes shot finally gets the green light from regulators.

Feb 1, 2012 11:42AM on Top StocksBy MSN Money Partner

Seagate is upgraded to 'overweight,' while T. Rowe Price is downgraded to 'sell.'

Jan 30, 2012 3:13PM on Top StocksBy Minyanville

U.S. clearance is a major milestone, but Bydureon faces stiff competition from its fast-selling rival.




Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.